Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14279/23068
Title: Therapeutic strategies for multiple sclerosis: Current data
Authors: Georgiou, Anastasios M. 
Major Field of Science: Medical and Health Sciences
Field Category: Clinical Medicine
Keywords: Disease‑modifying therapies;Multiple sclerosis;Neuroprotective strategies
Issue Date: Mar-2015
Source: International Journal of Health & Allied Sciences, vol. 4, no, 1, pp. 3-8
Volume: 4
Issue: 1
Start page: 3
End page: 8
Journal: International Journal of Health & Allied Sciences 
Abstract: At present, the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved drugs for Relapsing Remitting Multiple Sclerosis (RRMS) and Secondary Progressive MS (SPMS). In this paper, modern therapeutic strategies for MS are reviewed. A comprehensive research in MEDLINE, PUBMED, and SCIENCEDIRECT databases using two Boolean phrases {i.e. 1. [(Multiple Sclerosis) and (Disease Modifying Therapies)] and 2. [(Multiple Sclerosis) and (Neuroprotective Therapies)]} yielded more than 1,5000 articles in total. Therefore, for the purposes of this paper, articles written within the last decade were considered for review.
URI: https://hdl.handle.net/20.500.14279/23068
ISSN: 2278344X
DOI: 10.4103/2278-344X.149199
Rights: Attribution-NonCommercial-NoDerivatives 4.0 International
Type: Article
Affiliation : James Cook University 
Publication Type: Peer Reviewed
Appears in Collections:Άρθρα/Articles

Files in This Item:
File Description SizeFormat
IntJHealthAlliedSci413-1951091_052510.pdfFulltext558.31 kBAdobe PDFView/Open
CORE Recommender
Show full item record

Page view(s)

274
Last Week
1
Last month
4
checked on Nov 13, 2024

Download(s)

194
checked on Nov 13, 2024

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons